Company profile
Mint Diagnostics Ltd
Hormonix
Mint Diagnostics Ltd is a UK company with status active founded in 2016 based in East of England.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
InsolvencyLIQ03 | Transaction MzQzNDY0OTI3OWFkaXF6a2N4 | Paper/PDF filed
Published 13 Sep 2024 12:48
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development and Manufacturing of salivary Point-of-Care tests
1 Apr 2021 to 30 Sep 2022
Hormone levels impact countless aspects of daily life, from mood and tiredness, to sporting performance, and medical treatment efficacy. Mint Diagnostics has made significant progress in developing Hormonix, our point-of-care diagnostics system for monitoring steroid hormones in saliva, for human performance optimisation and personalised healthcare. This ...
Hormonix: fully automated low-cost salivary hormone monitoring
1 Nov 2020 to 30 Apr 2022
Mint Diagnostics is redefining how data on hormone levels can be monitored and used to improve human performance. Combining our proprietary salivary testing and analysis technology with advanced data interpretation, we enable precise monitoring of performance within a variety of contexts, from elite sports to health and wellness. Our project is supported ...
Mobile hormone monitoring platform for cancer management
1 May 2019 to 31 Jan 2020
We will assess the market and technical feasibility of a new companion device for cancer treatment and management. The technology will enable clinicians to monitor the hormone levels of their patients in real-time, and from such information it will be possible to precisely optimise treatments and management programmes.
Point-of-care diagnostics for stress monitoring based on graphene-aptamer technology
1 May 2017 to 31 Dec 2017
We combine the two emerging technologies of graphene and aptamers to realise a portable personal device for monitoring stress levels. The product offers a 'personal anti-stress coach' service, via a combination of biosensing functionalities and data interpretation, with a dedicated mobile application and a user-centric design. The product goes beyond the ...